PROVECTUS BIOPHARMACEUTICALS, INC. 4
4 · PROVECTUS BIOPHARMACEUTICALS, INC. · Filed Dec 10, 2015
Insider Transaction Report
Form 4
DEES H CRAIG
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2015-12-09+400,000→ 400,000 totalExercise: $0.75From: 2015-12-09Exp: 2025-12-09→ Common Stock (400,000 underlying)